Literature DB >> 8077303

Complex alteration of thyroid function in healthy centenarians.

S Mariotti1, G Barbesino, P Caturegli, L Bartalena, P Sansoni, F Fagnoni, D Monti, U Fagiolo, C Franceschi, A Pinchera.   

Abstract

Several changes in thyroid function have been described in the elderly and largely attributed to concomitant nonthyroidal illness. The extent to which aging per se contributes to these changes remains to be elucidated, and scanty data are available in extremely old subjects. The present study was designed to focus on thyroid function during physiological aging, taking advantage of two groups of selected aged individuals: group A of healthy centenarians (n = 41; age range, 100-110 yr) and group B including healthy elderly subjects selected by the criteria of the EURAGE SENIEUR protocol (n = 33; age range, 65-80 yr). Control groups included 98 healthy normal adult subjects (group C; age range, 20-64 yr) and 52 patients with miscellaneous nonthyroidal illness (group D; age range, 28-82 yr). Our previous report of a low prevalence of thyroid autoantibodies in centenarians was confirmed and extended by the finding of a similar low autoantibody prevalence in the highly selected healthy elderly population of group B. Subclinical primary hypothyroidism was found in 3 (7.3%) centenarians, and their data were excluded from further statistical evaluation. No significant difference was found in the median serum free T4 levels of groups A-C. Median (and range) serum free T3 (FT3) was lower in centenarians [3.67 pmol/L (2.3-5.5)] than in group B [5.22 pmol/L (3.4-6.1)] and group C [5.38 pmol/L (2.9-8.4); P < 0.0001 vs. both groups]. Similarly, the median serum TSH level of centenarians [0.97 mU/L (< 0.09 to 2.28)] was lower than those in groups B [1.17 mU/L (0.53-2.74)] and C [1.7 mU/L (0.4-4.8); P < 0.0001 vs. both groups]; moreover, serum TSH was also significantly (P < 0.01) lower in group B than in group C. Both serum FT3 and TSH concentrations showed a significant inverse correlation (r = -0.634; P < 0.0001 and r = -0.377; P < 0.0001, respectively) with age. Median serum FT3 in centenarians was lower than that in group D patients [4.61 pmol/L (2.15-6.6); P < 0.0001]. In contrast, median serum rT3 in centenarians [0.40 nmol/L (0.20-0.77)], although higher than those in groups B [0.24 nmol/L (0.15-0.37); P < 0.0001] and C [0.22 nmol/L (0.05-0.46); P < 0.0001], was significantly lower than that in group D [0.60 nmol/L (0.13-2.08); P < 0.0001]. In conclusion, thyroid function appears to be well preserved until the eighth decade of life if healthy subjects are studied, whereas a reduction of serum FT3 is observed in extreme aging.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8077303     DOI: 10.1210/jcem.77.5.8077303

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

Review 1.  Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

Authors:  S S Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study.

Authors:  Graziano Ceresini; Fulvio Lauretani; Marcello Maggio; Gian Paolo Ceda; Simonetta Morganti; Elisa Usberti; Carlo Chezzi; Rita Valcavi; Stefania Bandinelli; Jack M Guralnik; Anne R Cappola; Giorgio Valenti; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2008-11-19       Impact factor: 5.562

3.  Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient.

Authors:  Joanna Klubo-Gwiezdzinska; Leonard Wartofsky
Journal:  Arch Intern Med       Date:  2009-11-23

4.  Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study.

Authors:  Avantika C Waring; Alice M Arnold; Anne B Newman; Petra Bùzková; Calvin Hirsch; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2012-08-09       Impact factor: 5.958

Review 5.  Approach to and treatment of thyroid disorders in the elderly.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Med Clin North Am       Date:  2012-02-14       Impact factor: 5.456

Review 6.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

7.  Age and the thyrotropin response to hypothyroxinemia.

Authors:  Rebecca Over; Sonia Mannan; Hala Nsouli-Maktabi; Kenneth D Burman; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 8.  Thyroid disease in older patients. Diagnosis and treatment.

Authors:  P Finucane; C Anderson
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

9.  A cross-section analysis of FT3 age-related changes in a group of old and oldest-old subjects, including centenarians' relatives, shows that a down-regulated thyroid function has a familial component and is related to longevity.

Authors:  Andrea Corsonello; Alberto Montesanto; Maurizio Berardelli; Francesco De Rango; Serena Dato; Vincenzo Mari; Bruno Mazzei; Fabrizia Lattanzio; Giuseppe Passarino
Journal:  Age Ageing       Date:  2010-09-15       Impact factor: 10.668

10.  Thyroid Function and Cognition during Aging.

Authors:  M E Bégin; M F Langlois; D Lorrain; S C Cunnane
Journal:  Curr Gerontol Geriatr Res       Date:  2008-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.